Skip to main content

X-Linked Severe Combined Immunodeficiency clinical trials at UCLA

2 in progress, 1 open to eligible people

Showing trials for
  • Lentiviral Gene Transfer for SCID-X1 with Low Dose Targeted Busulfan Conditioning

    open to eligible males ages 0-5

    This is a phase I/II open label multi-center study in which patients will receive low dose targeted busulfan followed by infusion of autologous CD34+ selected bone marrow or mobilized peripheral blood cells transduced with the G2SCID vector.…

    Los Angeles, California and other locations

  • Natural History Study of SCID Disorders

    Sorry, accepting new patients by invitation only

    This study is a prospective evaluation of children with Severe Combined Immune Deficiency (SCID) who are treated under a variety of protocols used by participating institutions. In order to determine the patient, recipient and transplant-related…

    Los Angeles, California and other locations

Our lead scientists for X-Linked Severe Combined Immunodeficiency research studies include .

Last updated: